Alexion Pharmaceuticals, Inc. (ALXN) Given Average Recommendation of "Buy" by Analysts


Shares of Alexion Pharmaceuticals, Inc. have been given a consensus recommendation of "Buy" by the twenty-four ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and eighteen have issued a buy recommendation on the company.



from Biotech News